These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8865474)

  • 41. Post-operative serial prostate-specific antigen and transrectal ultrasound for staging incidental carcinoma of the prostate.
    Feneley MR; Webb JA; McLean A; Kirby RS
    Br J Urol; 1995 Jan; 75(1):14-20. PubMed ID: 7531587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of changes in PSA in the management of men with prostate cancer.
    Carter HB; Pearson JD
    Semin Oncol; 1994 Oct; 21(5):554-9. PubMed ID: 7524154
    [No Abstract]   [Full Text] [Related]  

  • 43. Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma.
    Mistry K; Cable G
    J Am Board Fam Pract; 2003; 16(2):95-101. PubMed ID: 12665174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical significance of prostate specific antigen for early stage prostate cancer detection.
    Imai K; Ichinose Y; Kubota Y; Yamanaka H; Sato J; Saitoh M; Watanabe H; Ohe H
    Jpn J Clin Oncol; 1994 Jun; 24(3):160-5. PubMed ID: 7516445
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PSA and early prostate cancer detection: the importance of age-specific reference ranges.
    Oesterling JE
    Can J Oncol; 1994 Nov; 4 Suppl 1():52-6. PubMed ID: 8853490
    [No Abstract]   [Full Text] [Related]  

  • 46. [PSA screening--medically useful or superfluous?].
    Glatz U
    Dtsch Med Wochenschr; 2010 Jan; 135(4):p3. PubMed ID: 20101552
    [No Abstract]   [Full Text] [Related]  

  • 47. Volume adjustment for intermediate prostate-specific antigen values in a screening population.
    Bangma CH; Grobbee DE; Schröder FH
    Eur J Cancer; 1995; 31A(1):12-4. PubMed ID: 7535074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prostate-specific antigen in mass screening for carcinoma of the prostate.
    Shimizu TS; Uchida T; Satoh J; Imai K; Yamanaka H
    Int J Urol; 1995 Sep; 2(4):257-60. PubMed ID: 8564745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The value of prostatic specific antigen in the early diagnosis of prostatic cancer: a Greek view.
    Deliveliotis C; Alivizatos G; Karayiannis A; Kontothanasis D; Makrychoritis K; Lysiotis P; Dimopoulos MA
    Br J Urol; 1995 May; 75(5):637-41. PubMed ID: 7542133
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Screening test for prostate cancer].
    Imai K; Kubota Y; Yamanaka H
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):1923-7. PubMed ID: 7522000
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Significance of prostatic specific antigen in the mass screening for prostate cancer].
    Imai K; Suzuki T; Kuribara J; Ito K; Ootake N; Hatori M; Yamanaka H; Tomaru Y; Jinbo S; Kiren H
    Nihon Hinyokika Gakkai Zasshi; 1992 Sep; 83(9):1484-9. PubMed ID: 1279261
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The current and potential status of screening for prostatic cancer in asymptomatic populations.
    Murphy GP
    Prog Clin Biol Res; 1989; 303():19-25. PubMed ID: 2674985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density, and PSA change. Data from the American Cancer Society National Prostate Cancer Detection Project.
    Mettlin C; Littrup PJ; Kane RA; Murphy GP; Lee F; Chesley A; Badalament R; Mostofi FK
    Cancer; 1994 Sep; 74(5):1615-20. PubMed ID: 7520352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening for prostate cancer using serum prostate-specific antigen: a randomised, population-based pilot study in Finland.
    Auvinen A; Tammela T; Stenman UH; Uusi-Erkkilä I; Leinonen J; Schröder FH; Hakama M
    Br J Cancer; 1996 Aug; 74(4):568-72. PubMed ID: 8761371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mass screening for prostate carcinoma: a study in Hokkaido, Japan.
    Tsukamoto T; Kumamoto Y; Masumori N; Itoh N; Matsukawa M; Takahashi A; Umehara T; Takagi Y
    Eur Urol; 1995; 27(3):177-81. PubMed ID: 7541356
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Longitudinal screening for prostate cancer with prostate-specific antigen.
    Smith DS; Catalona WJ; Herschman JD
    JAMA; 1996 Oct 23-30; 276(16):1309-15. PubMed ID: 8861989
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening for prostate cancer utilizing the prostate-specific antigen (PSA).
    Halperin EC
    N C Med J; 1993 Sep; 54(9):443-6. PubMed ID: 7694161
    [No Abstract]   [Full Text] [Related]  

  • 58. Controversy in clinical cancer screening--prostate-specific antigen.
    McKay DA
    West J Med; 1994 Jul; 161(1):58-9. PubMed ID: 7524244
    [No Abstract]   [Full Text] [Related]  

  • 59. The new PSA report: understand the controversy.
    Harv Mens Health Watch; 2012 Feb; 16(7):1-4. PubMed ID: 22474703
    [No Abstract]   [Full Text] [Related]  

  • 60. Screening for prostate cancer. Comparison of transrectal ultrasound, prostate specific antigen and rectal examination.
    Perrin P; Maquet JH; Bringeon G; Devonec M
    Br J Urol; 1991 Sep; 68(3):263-5. PubMed ID: 1717096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.